Nephros News

Nephros | 10-Q: Q2 2024 Earnings Report

Aug 8 16:14 ET

Nephros | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 17 17:22 ET

Nephros | 4: Statement of changes in beneficial ownership of securities-Director Amron Arthur H

May 30 16:40 ET

Nephros | 8-K: Current report

May 24 16:08 ET

Nephros | EFFECT: Others

May 24 06:07 ET

Nephros | CORRESP: CORRESP

May 21 22:16 ET

Nephros | UPLOAD: Others

May 20 22:15 ET

Nephros | 4: Statement of changes in beneficial ownership of securities-Officer Banks Robert R. Jr.

May 16 16:52 ET

Nephros | 4: Statement of changes in beneficial ownership of securities-Director Amron Arthur H

May 16 16:33 ET

Nephros | 4: Statement of changes in beneficial ownership of securities-Director Lask Alisa

May 16 16:32 ET

Nephros | 4: Statement of changes in beneficial ownership of securities-Director Harris Joseph Michael

May 16 16:28 ET

Nephros | 4: Statement of changes in beneficial ownership of securities-Director Spandow Oliver J.

May 16 16:27 ET

Nephros | S-3: Registration statement for specified transactions by certain issuers

May 10 16:19 ET

Nephros | 10-Q: Q1 2024 Earnings Report

May 9 16:44 ET

Nephros | 8-K: Nephros Announces Financial Results for Quarter Ended March 31, 2024 First-Quarter Net Revenue of $3.5 Million; Technology advancements and microplastics capabilities on the horizon

May 9 16:26 ET

Nephros | 8-K: Current report

May 1 08:04 ET

Nephros | ARS: Annual Report to Security Holders

Apr 12 16:13 ET

Nephros | DEFA14A: Others

Apr 12 16:09 ET

Nephros | DEF 14A: Definitive information statements

Apr 12 16:03 ET

Nephros | 10-K: FY2023 Annual Report

Mar 15 16:33 ET